Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Aclidinium/Formoterol FDC vs Formoterol in COPD
NCT01437540Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aclidinium in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Sep 2011; status: completed.
02
Drugs
aclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01437540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437540.